OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
New & Niche Drugs
13 minutes
Posted Jan 10, 2019 at 6:26 pm.
0:00
13:57
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).
Previous
mFOLFIRINOX
Next
Conversation With An Osteosarcoma Survivor
← See all 273 episodes of OncoPharm
